Drug Delivery and Translational Research

期刊基本信息

  • 期刊名称:Drug Delivery and Translational Research
  • 期刊级别: Science Citation Index Expanded (SCIE) Scopus (CiteScore)
  • 期刊ISSN:2190-393X
  • 期刊EISSN:2190-3948
  • 简称:DRUG DELIV TRANSL RE
  • 影响因子:5.5
  • 实时影响因子:截止2025年5月19日:5.406
  • 五年影响因子:6.2
  • JCI期刊引文指标:1.35
  • h-index:27
  • 2024-2025自引率:3.60%
  • 期刊官方网站:期刊官方网站
  • 期刊投稿网址:https://www.editorialmanager.com/DDTR
  • 是否OA开放访问:No
  • 出版商:Springer US
  • 出版年份:2011

Drug Delivery and Translational Research

Science Citation Index Expanded (SCIE)Scopus (CiteScore)

期刊介绍

The journal provides a unique forum for scientific publication of high-quality research that is exclusively focused on translational aspects of drug delivery. Rationally developed, effective delivery systems can potentially affect clinical outcome in different disease conditions.

Research focused on the following areas of translational drug delivery research will be considered for publication in the journal.

Designing and developing novel drug delivery systems, with a focus on their application to disease conditions;
Preclinical and clinical data related to drug delivery systems;
Drug distribution, pharmacokinetics, clearance, with drug delivery systems as compared to traditional dosing to demonstrate beneficial outcomes
Short-term and long-term biocompatibility of drug delivery systems, host response;
Biomaterials with growth factors for stem-cell differentiation in regenerative medicine and tissue engineering;
Image-guided drug therapy,
Nanomedicine;
Devices for drug delivery and drug/device combination products.
In addition to original full-length papers, communications, and reviews, the journal includes editorials, reports of future meetings, research highlights, and announcements pertaining to the activities of the Controlled Release Society.

期刊语言要求

Language
Presenting your work in a well-structured manuscript and in well-written English gives it its best chance for editors and reviewers to understand it and evaluate it fairly. Many researchers find that getting some independent support helps them present their results in the best possible light.

投稿要求

  • 通讯方式:TIERGARTENSTRASSE 17, HEIDELBERG, GERMANY, D-69121
  • 涉及的研究方向:MEDICINE, RESEARCH & EXPERIMENTALPHARMACOL-PHARMACOLOGY & PHARMACY
  • 出版国家或地区:GERMANY
  • 出版语言:English
  • 年文章数:244
  • PubMed Central (PMC)链接:http://www.ncbi.nlm.nih.gov/nlmcatalog?term=2190-393X%5BISSN%5D

CITESCORE

CiteScoreSJRSNIPCiteScore排名
12.701.1751.259
学科分区排名百分位
大类:Pharmacology, Toxicology and Pharmaceutics
小类:Pharmaceutical Science
Q19 / 185
95%

WOS期刊JCR分区

WOS分区等级:1区

按JIF指标学科分区收录子集JIF分区JIF排名JIF百分位
学科:MEDICINE, RESEARCH & EXPERIMENTALSCIEQ141/195
79.2%
学科:PHARMACOLOGY & PHARMACYSCIEQ134/352
90.5%
按JCI指标学科分区收录子集JCI分区JCI排名JCI百分位
学科:MEDICINE, RESEARCH & EXPERIMENTALSCIEQ130/195
84.87%
学科:PHARMACOLOGY & PHARMACYSCIEQ137/353
89.66%

期刊分区表预警名单

2025年03月发布的2025版:不在预警名单中

2024年02月发布的2024版:不在预警名单中

2023年01月发布的2023版:不在预警名单中

2021年12月发布的2021版:不在预警名单中

2020年12月发布的2020版:不在预警名单中

中科院2025年3月升级版

点击查看中国科学院期刊分区趋势图
大类学科小类学科Top期刊综述期刊
医学 1区3区1区
MEDICINE, RESEARCH & EXPERIMENTAL
医学:研究与实验
1区1区3区
PHARMACOLOGY & PHARMACY
药学
4区4区3区

中科院2023年12月旧的升级版

大类学科小类学科Top期刊综述期刊
医学 1区3区1区
PHARMACOLOGY & PHARMACY
药学
3区2区2区
MEDICINE, RESEARCH & EXPERIMENTAL
医学:研究与实验
1区2区3区

联系我们

QQ:1211130760

微信:iqkan555

微信扫码加好友 微信扫码加好友
QQ扫码加好友 QQ扫码加好友